ORIGIN THERAPEUTICS
Origin Therapeutics focuses on companies with a management team and high growth potential.
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-07-07 | Clairvoyant Therapeutics | Origin Therapeutics investment in Seed Round - Clairvoyant Therapeutics | N/A |
More informations about "Origin Therapeutics"
Newsroom - Origin Therapeutics
Origin Therapeutics Holdings Inc. announces that it has filed its preliminary long form prospectus dated August 30, 2021 with the securities regulatory authorities in the provinces of British …See details»
CORPORATE PRESENTATION - originpsychedelics.com
ORIGIN THERAPEUTICS 15 Kyle Gould is a Co-Founder of Hyperion Capital Inc., a boutique advisory firm specializing in the Healthcare and Technology Sectors. ... Jonathan is a member …See details»
Origin Therapeutics adds Clairvoyant Therapeutics to its
Jul 7, 2022 According to the World Health Organization, 283 million 1 people aged 15 years and older live with AUD, accounting for 5.1% of the global adult population. Alcohol dependence, …See details»
Origin Therapeutics adds Clairvoyant Therapeutics to its Portfolio
Jul 7, 2022 Origin Therapeutics Holdings Inc (the “Company” or “Origin Therapeutics”) is an actively managed investment issuer focused on making equity investments in psychedelics …See details»
Origin Therapeutics’ Portfolio Company, Clairvoyant, Approved for …
Oct 18, 2022 Origin Therapeutics Holdings Inc. (the “Company” or “Origin Therapeutics”) is an actively managed investment issuer focused on making equity investments in psychedelics …See details»
Origin Therapeutics Closes $6.5 Million Private Placement to Fund …
Aug 12, 2021 Origin Therapeutics Holdings Inc. (CSE: ORIG Proposed) (the “Company” or “Origin Therapeutics”) is an actively managed investment issuer focused on making equity …See details»
Origin Therapeutics’ Portfolio Company, Xpira Pharmaceuticals, …
Sep 22, 2022 Origin Therapeutics’ Portfolio Company, Xpira Pharmaceuticals, Receives FDA Approval For Psilocybin Trial IND Application Origin Therapeutics Holdings Inc. Thu, Sep 22, …See details»
Origin Therapeutics’ Portfolio Company, Clairvoyant ... - BioSpace
Oct 18, 2022 Origin Therapeutics Holdings Inc.(CSE: ORIG) (the “Company”, “Origin Therapeutics” or “Origin”) today announced that one of its portfolio companies, Clairvoyant …See details»
Origin Therapeutics - Crunchbase Investor Profile & Investments
Origin Therapeutics focuses on companies with a management team and high growth potential. Lists Featuring This Company. Edit Lists Featuring This Company Section. Canada Investors . …See details»
Origin Therapeutics' Portfolio Company, Clairvoyant, Approved for …
Oct 18, 2022 (the “Company”, “Origin Therapeutics” or “Origin”), an actively managed, psychedelics industry-focused investment issuer, today announced that one of its portfolio …See details»
Origin Therapeutics Launches to Invest in Psychedelics Startups …
Aug 5, 2021 The company in question is Origin Therapeutics, which launched last month in Vancouver, British Columbia. The new actively managed investment issuer plans to list on …See details»
Origin Therapeutics Company Profile 2024: Valuation, Investors ...
Origin Therapeutics has 3 total employees. What industry is Origin Therapeutics in? Origin Therapeutics’s primary industry is Other Financial Services. Is Origin Therapeutics a private or …See details»
Investors - Origin Therapeutics
Investors We provide access to exclusive opportunities Our experienced team of founders, board of directors and management team has access to a diverse deal pipeline and has the requisite …See details»
Origin Therapeutics’ Portfolio Company, Xpira - GlobeNewswire
Sep 22, 2022 Origin Therapeutics Holdings Inc. (the “Company” or “Origin Therapeutics”) is an actively managed investment issuer focused on making equity investments in psychedelics …See details»
Origin Therapeutics Launches to Fund Emerging Psychedelics
Jul 21, 2021 Origin Therapeutics Holdings Inc. (CSE: ORIG Proposed) (the “Company” or “Origin Therapeutics”) is an actively managed investment issuer focused on making equity …See details»
Origin Therapeutics Announces New Director - Yahoo Finance
Origin Therapeutics is an actively managed investment issuer focused on making equity investments in psychedelics industry-related companies to provide investors with diverse …See details»
Origin Therapeutics - Investments, Portfolio & Company Exits
Jul 7, 2022 Origin Therapeutics has invested in Clairvoyant Therapeutics on Jul 7, 2022. How many investments has this organization made over time? Show . Which industries has this …See details»
Origen Therapeutics - Crunchbase Company Profile & Funding
Origen Therapeutics, Inc., a biotechnology company, develops products from avian transgenic animal technology. It provides human sequence polyclonal antibodies. The company also …See details»